0001127602-21-021239.txt : 20210702 0001127602-21-021239.hdr.sgml : 20210702 20210702161915 ACCESSION NUMBER: 0001127602-21-021239 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210701 FILED AS OF DATE: 20210702 DATE AS OF CHANGE: 20210702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANSTICE DAVID W CENTRAL INDEX KEY: 0001181171 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 211070354 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-07-01 0001520262 Alkermes plc. ALKS 0001181171 ANSTICE DAVID W CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 Ordinary Shares 2021-07-01 4 M 0 20000 14.60 A 93081 D Ordinary Shares 2021-07-01 4 S 0 20000 24.5752 D 73081 D Non Qualified Stock Option (Right to Buy) 14.60 2021-07-01 4 M 0 20000 0 D 2021-10-05 Ordinary Shares 20000 0 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.48 to $24.73. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Shantale Greenson, attorney-in-fact for David W. Anstice 2021-07-02